跳至主要内容
临床试验/NCT04814550
NCT04814550已完成不适用

Angiography-Derived Fractional Flow Reserve for Functional Evaluation of Coronary Artery Disease

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 318 人开始时间: 2020年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
318
试验地点
1
主要终点
Diagnostic accuracy of AccuFFRangio to determine hemodynamically significant coronary artery stenosis compared to FFR as the reference standard

研究概览

简要总结

This is a prospective, multicenter, self-control clinical trial designed to assess the efficacy of AccuFFRangio, a novel method for evaluating the functional significance of coronary stenosis from coronary angiography, with FFR as the reference standard.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years;
  • Stable or unstable angina, or myocardial infarction after the acute phase, indication for FFR in at least one vessel;
  • Able to provide informed consent.

排除标准

  • Subjects judged unsuitable for diagnostic intervention or FFR;
  • Myocardial infarction within 6 days;
  • LVEF ≤50%;
  • eGFR <60ml/min(1.73m²)
  • Severe coagulation dysfunction or bleeding disorders;
  • Allergic to iodine contrast agent or adenosine, or ineligible for adenosine;
  • Participated in other clinical trials within 1 months;
  • Other situations that were not suitable for inclusion, as judged by investigators.

结局指标

主要结局

Diagnostic accuracy of AccuFFRangio to determine hemodynamically significant coronary artery stenosis compared to FFR as the reference standard

时间窗: 7 days

Hemodynamically significant coronary artery stenosis: FFR≤0.8

次要结局

  • Sensitivity and specificity of AccuFFRangio to determine hemodynamically significant coronary artery stenosis compared to FFR as the reference standard(7 days)
  • AUC of AccuFFRangio for discrimination of hemodynamically significant coronary artery stenosis(7 days)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验